GLP-1 analogues in the treatment of obesity and non-alcoholic fatty liver disease
Authors
Kacper Deska
Medical University of Lodz: Uniwersytet Medyczny w Lodzi, Łódź, POLAND
Bartłomiej Bąk
Military Medical Academy Memorial University Teaching Hospital in Łódź
Marcin Kosmalski
Department of Clinical Pharmacology, 1st Chair of Internal Medicine, Norbert Barlicki Memorial University Teaching Hospital No. 1 in Łódź
Tadeusz Pietras
Department of Clinical Pharmacology, 1st Chair of Internal Medicine, Norbert Barlicki Memorial University Teaching Hospital No. 1 in Łódź
DOI: https://doi.org/10.2478/ahem-2023-0001 | Journal eISSN: 1732-2693
Language: English
Page range: 1 - 8
Submitted on: Apr 5, 2022
Accepted on: Oct 20, 2022
Published on: Feb 28, 2023
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2023 Kacper Deska, Bartłomiej Bąk, Marcin Kosmalski, Tadeusz Pietras, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.